Home › NDC Lookup › Ingredients › Dextromethorphan Hbr Guaifenesin › 70677-1185-01
Tussin DM Dextromethorphan HBr, Guaifenesin 200 mg/20mL; 20 mg/20mL Syrup — NDC 70677-1185-01 package photo

Tussin DM Dextromethorphan HBr, Guaifenesin 200 mg/20mL; 20 mg/20mL Syrup

by Strategic Sourcing Service, LLC · 1 BOTTLE in 1 CARTON (70677-1185-1) / 118 mL in 1 BOTTLE
NDC 70677-1185-01
🏷️ FDA NDC (as labeled) 70677-1185-1 billing pads the package segment with a zero
This package
Contains118 mL in 1 bottle Cost per mL$0.0203 NADAC Per package$2.40 / 118 ml Pack sizes2 compare ↓
Also priced by: Medicaid pays $0.0723/unit — full pricing hub ↓
Also comes in: 236 mL 70677-1185-02
OTC On market Non-controlled
🗂️ Data synced Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 70677-1185-1
Product NDC 70677-1185
11-digit billing NDC 70677118501
NCPDP billing unit ML — per mL (volume)
RxCUI 1790650
UNII 495W7451VQ, 9D2RTI9KYH
Application # M012
SPL Set ID 0b6689db-ea34-9a06-e063-6394a90abaf7
Established class (EPC) Expectorant
Physiologic effect Decreased Respiratory Secretion Viscosity; Increased Respiratory Secretions
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-06-01
Route ORAL
Dosage form SYRUP
Substance GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE
GCN Seq No 079414
GCN 45903
HICL code 000223
Ingredient (HICL) Guaifenesin/Dextromethorphan
HIC1 code B
Therapeutic class — broad (HIC1) Respiratory System
HIC2 code B3
Therapeutic class — intermediate (HIC2) Drugs Affecting Primarily The Trachea And Bronchi
HIC3 code B3T
Therapeutic class — specific (HIC3) Non-Opioid Antitussive And Expectorant Combination
AHFS code 48:08.00.00
AHFS class Antitussives
FDB label name FT TUSSIN DM 200-20 MG/20 ML
FDB brand name Tussin Dm
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 70677-1185-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70677-1185-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Uncompetitive N-methyl-D-aspartate Receptor Antagonist class.

Pharmacologic class Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Sigma-1 Agonist
Drug family (ATC) Other antidepressants, Opium alkaloids and derivatives
How it works Uncompetitive NMDA Receptor Antagonists, Sigma-1 Receptor Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerStrategic Sourcing Service, LLC
FDA applicationM012 (OTC MONOGRAPH DRUG)
Labeler code70677
First marketedJun 2023
Product typeHuman Otc Drug
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name FT TUSSIN DM 200-20 MG/20 ML Ingredient Guaifenesin/Dextromethorphan
📗 Our plain-language guide HelloPharmacist
  • The two ingredients tackle your symptoms from different angles. Guaifenesin is an expectorant — it helps thin and loosen the mucus in your chest so you can cough it up more easily....
  • What exactly does this combination do — why are two ingredients needed?
  • It depends on which antidepressant you're taking. If it's a type called an MAOI — which includes certain older antidepressants and some medications for Parkinson's disease — you sh...
  • Can I take this if I'm on an antidepressant?
📖 Read our full Dextromethorphan / Guaifenesin guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII XF417D3PSL
    Anhydrous citric acid is a sour, crystalline powder derived from citric acid with water removed. In medicines, it acts as a buffer to control pH, adds tartness to improve taste, and helps tablets disintegrate.
  • UNII K679OBS311
    Carboxymethylcellulose sodium is a plant-derived thickening agent made from cellulose. In medicines, it acts as a binder to hold ingredients together, a disintegrant to help the tablet break apart, or a thickener in liquids.
  • UNII PDC6A3C0OX
    Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
  • UNII L7T10EIP3A
    A cooling compound from mint plants used as a flavoring agent and to create a fresh sensation in medicines. It helps mask bitter tastes and improve how the product feels in the mouth.
  • UNII B697894SGQ
    Polyethylene glycol 400 is a clear, thick liquid made from petroleum-derived polymers. It acts as a solvent and humectant in medicines, helping dissolve active ingredients and retain moisture in the formulation.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII OJ245FE5EU
    Sodium benzoate is a salt derived from benzoic acid, a preservative. It's added to medicines to prevent growth of bacteria, fungi, and other microorganisms that could spoil the product.
  • UNII 1Q73Q2JULR
    Sodium citrate is a salt derived from citric acid. It works as a buffer to maintain the medicine's pH level and may also help improve taste or act as a preservative in the formulation.
  • UNII R6Q3791S76
    Sodium gluconate is a salt derived from gluconic acid, a naturally occurring compound. In medicines, it functions as a buffering agent to help maintain stable pH and as a chelating agent that can bind minerals in formulations.
  • UNII 96K6UQ3ZD4
    Sucralose is a synthetic sweetener made from sugar. It's added to medicines to improve taste without adding calories, helping make bitter or unpleasant-tasting drugs easier to take.
  • UNII XHX3C3X673
    Triacetin is a clear, oily liquid made from glycerin and acetic acid. It works as a plasticizer and solvent in medicines, helping soften coatings and improve how liquids mix together in formulations.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
  • UNII TTV12P4NEE
    Xanthan gum is a thickening and stabilizing ingredient made from fermented corn or other sugars. It's added to medicines to improve texture, prevent separation of liquids and solids, and help the product stay consistent.

13 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescarboxymethylcellulose sodium, citric acid (anhydrous), flavor, glycerin, menthol, polyethylene glycol, propylene glycol, purified water, sodium benzoate, sodium citrate, sodium gluconate, sucralose, triacetin, xanthan gum

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.020 $2.40 / 118 ml
Medicaid paysCMS SDUD · 12 mo $0.0723 $8.53 / 118 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Dec 2025 Feb 2026 Apr 2026 Jun 2026 $0.020 $0.020
Flat over the last 7 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Neighbor Dye Free Adult Tussin DM Cough and Chest Congestion 20 mg/20mL; 200 mg/20mL 46122-0783-34 AMERISOURCE 1 bottle $0.015 — Availability likely save 28%
rugby cough syrup 20 mg/20mL; 200 mg/20mL 00536-1348-97 Rugby 1 bottle $0.017 — Availability likely save 17%
Tussin DM 200 mg/20mL; 20 mg/20mLthis 70677-1185-01 Strategic 1 bottle $0.020 — Availability likely —
good sense tussin dm 20 mg/20mL; 200 mg/20mL 00113-1725-26 L. 1 bottle $0.021 — Availability likely +1%
robafen dm 20 mg/20mL; 200 mg/20mL 00904-7223-20 Major 1 bottle $0.021 — Availability likely +1%
Robafen DM Cough 20 mg/20mL; 200 mg/20mL 00904-7441-20 Major 1 bottle $0.021 — Availability likely +1%
good neighbor pharmacy adult tussin DM 20 mg/20mL; 200 mg/20mL 46122-0704-26 Amerisource 1 bottle $0.021 — Availability likely +1%
Good Neighbor Sugar Free Adult Tussin DM Cough and Chest Congestion 20 mg/20mL; 200 mg/20mL 46122-0782-29 AMERISOURCE 1 bottle $0.021 — Availability likely +1%
Tussin DM 20 mg/20mL; 200 mg/20mL 70000-0670-01 Cardinal 1 bottle $0.021 — Availability likely +1%
foster and thrive adult tussin dm 20 mg/20mL; 200 mg/20mL 70677-1035-01 Strategic 1 bottle $0.021 — Availability likely +1%
Tussin DM 20 mg/20mL; 200 mg/20mL 70677-1261-01 Strategic 1 bottle $0.021 — Availability likely +1%
QCH Adult Tussin DM 542 20 mg/20mL; 200 mg/20mL 83324-0023-04 Chain 1 bottle $0.021 — Availability likely +1%
QCH Adult Tussin DM Sugar free 545 20 mg/20mL; 200 mg/20mL 83324-0025-04 Chain 1 bottle $0.021 — Availability likely +1%
Childrens Robitussin Cough and Chest Congestion DM 20 mg/20mL; 200 mg/20mL 00031-8702-13 Haleon 1 bottle — — FDA listed —
Robitussin Cough Plus Chest Congestion Dm 20 mg/20mL; 200 mg/20mL 00031-8757-12 Haleon 1 bottle — — FDA listed —
Robitussin Sugar-Free Dye-Free Cough Plus Chest Congestion DM 20 mg/20mL; 200 mg/20mL 00031-8759-12 Haleon 1 bottle — — FDA listed —
Childrens Robitussin Honey Cough and Chest Congestion DM 10 mg/10mL; 100 mg/10mL 00031-8760-12 Haleon 1 bottle — — FDA listed —
adult tussin dm 20 mg/20mL; 200 mg/20mL 00363-1603-26 Walgreen 1 bottle — — FDA listed —
Walgreen Adult Cough Plus Chest Congestion Dm 20 mg/20mL; 200 mg/20mL 00363-7440-08 WALGREEN 1 bottle — — FDA listed —
Walgreens Grape Flavor 20 mg/20mL; 200 mg/20mL 00363-7470-04 WALGREENS 1 bottle — — FDA listed —
tussin cough and chest congestion 20 mg/20mL; 200 mg/20mL 11822-1630-00 Rite 1 bottle — — FDA listed —
equaline adult tussin 20 mg/20mL; 200 mg/20mL 41163-0813-26 United 1 bottle — — FDA listed —
Robafen Dm 20 mg/20mL; 200 mg/20mL 50090-6747-00 A-S 1 bottle — — FDA listed —
good sense tussin dm 20 mg/20mL; 200 mg/20mL 50090-7257-00 A-S 1 bottle — — FDA listed —
Cough And Chest Congestion 20 mg/20mL; 200 mg/20mL 51316-0082-34 CVS 1 bottle — — FDA listed —
Cough And Chest Congestion Dm 20 mg/20mL; 200 mg/20mL 51316-0473-34 CVS 1 bottle — — FDA listed —
Cvs Adult Cough Plus Chest Congestion Dm 20 mg/20mL; 200 mg/20mL 51316-0744-08 CVS 1 bottle — — FDA listed —
dg health adult tussin 20 mg/20mL; 200 mg/20mL 55910-0776-26 Dolgencorp 1 bottle — — FDA listed —
adult tussin dm 20 mg/20mL; 200 mg/20mL 56062-0607-26 Publix 1 bottle — — FDA listed —
tussin 20 mg/20mL; 200 mg/20mL 59640-0100-26 H 1 bottle — — FDA listed —
Premier Value 20 mg/20mL; 200 mg/20mL 68016-0744-04 PHARMACY 1 bottle — — FDA listed —
DRx Choice Children daytime Cough and Chest Congestion 20 mg/20mL; 200 mg/20mL 68163-0747-04 RARITAN 1 bottle — — FDA listed —
robafen dm 20 mg/20mL; 200 mg/20mL 68788-8268-01 Preferred 1 bottle — — FDA listed —
good sense tussin dm 20 mg/20mL; 200 mg/20mL 68788-8300-01 Preferred 1 bottle — — FDA listed —
rugby cough syrup 20 mg/20mL; 200 mg/20mL 68788-8303-01 Preferred 1 bottle — — FDA listed —
adult tussin dm 20 mg/20mL; 200 mg/20mL 69842-0513-26 CVS 1 bottle — — FDA listed —
leader tussin dm 20 mg/20mL; 200 mg/20mL 70000-0596-01 Cardinal 1 bottle — — FDA listed —
Tussin DM Cough plus Chest Congestion 20 mg/20mL; 200 mg/20mL 70000-0713-01 Cardinal 1 bottle — — FDA listed —
basic care tussin dm 20 mg/20mL; 200 mg/20mL 72288-0631-26 Amazon.com 1 bottle — — FDA listed —
careone tussin dm 20 mg/20mL; 200 mg/20mL 72476-0630-26 Retail 1 bottle — — FDA listed —
topcare tussin dm 20 mg/20mL; 200 mg/20mL 76162-0600-26 Topco 1 bottle — — FDA listed —
adult cough and chest congestion 20 mg/20mL; 200 mg/20mL 79481-0063-00 Meijer, 1 bottle — — FDA listed —
Meijer Children Cough and Chest Congestion DM Grape Flavor 20 mg/20mL; 200 mg/20mL 79481-7470-08 MEIJER 1 bottle — — FDA listed —
equate adult cough and chest congestion dm 20 mg/20mL; 200 mg/20mL 79903-0095-08 WALMART 1 bottle — — FDA listed —
Tussin DM 20 mg/20mL; 200 mg/20mL 83324-0327-04 Chain 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2023
On the market since
Jun 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 70677-1185-01, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
581
Units reimbursed last 4 qtrs
117.4K
Gross reimbursed last 4 qtrs
$8.5K
Avg / prescription
$14.60
Avg / unit
$0.0723
Latest quarter Q4 2025
112Rx
Medicaid pays / mL
$0.0723
gross reimbursed
vs
NADAC / mL
$0.0203
acquisition cost
=
Spread
+$0.0520
+256% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
100% FFS
Fee-for-service · 581 Rx Managed care · 0 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: no data reported MI New York: 72,863 units · 372 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: no data reported OH Pennsylvania: no data reported PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: 44,522 units · 114 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
114372
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 372 /100k
2 California 114 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

💊 Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
1 bottle70677-1185-02 1,328 Rx · $19,532
1 bottle this page70677-1185-01 581 Rx · $8,484
Drug total (last 4 qtrs): 1,909 Rx · 469,576 units · $28,016 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Dextromethorphan HBr Guaifenesin — the ingredient across all brands.

Top reported reactions

Dyspnoea140
Pneumonia123
Nausea120
Cough119
Fatigue118
Diarrhoea106
Pain87

Age at onset

Child1
Adolescent1
Adult76
Elderly72

Reporter sex

1,675 reports
Male · 37%
Female · 62%
Unknown · 1%

Serious outcomes

Hospitalization548
Death155
Life-threatening54
Disabling49
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 153 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startStatus
70677-1185-01 You're viewing this 1 BOTTLE in 1 CARTON (70677-1185-1) / 118 mL in 1 BOTTLE $0.0203 / mL $2.39 2023-06-01 Active
70677-1185-02 1 BOTTLE in 1 CARTON (70677-1185-2) / 236 mL in 1 BOTTLE $0.0154 / mL $3.62 2023-06-01 Active

Per mL, this pack runs about 32% above the cheapest pack (NDC 70677-1185-02, $0.0154 vs $0.0203 NADAC).

This pack accounts for about 30% of this product's recent Medicaid fills; most go to a different pack size. See all packs ↓

Pack size FAQ

What quantity is in NDC 70677-1185-01?
NDC 70677-1185-01 is listed by the FDA — 1 bottle in 1 carton / 118 ml in 1 bottle.
What NDC number is used to bill for this package of Tussin DM Dextromethorphan HBr, Guaifenesin 200 mg/20mL; 20 mg/20mL Syrup?
Bill NDC 70677-1185-01 — the 11-digit billing format is 70677118501. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 43 words ▾

Uses helps loosen phlegm (mucus) and thin bronchial secretions to: drain bronchial tubes make coughs more productive rid bronchial passageways of bothersome mucus temporarily relieve cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants

⏱️ Dosage and Administration 34 words ▾

Directions take every 4 hours do not take more than 6 doses in 24 hours adults and children 12 years and over 40 mL every 4 hours children under 12 years do not use

⚠️ Warnings 153 words ▾

Warnings Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have cough that occurs with too much phlegm (mucus) cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema Stop use and ask a doctor if cough lasts for more than 1 week, comes back, or occurs with a fever, rash, or headache that lasts.

These could be signs of a serious condition. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 15 words ▾

Active ingredients (in each 20 mL) Dextromethorphan HBr, USP 20 mg Guaifenesin, USP 200 mg

🧪 Inactive Ingredients 26 words ▾

Inactive ingredients carboxymethylcellulose sodium, citric acid (anhydrous), flavor, glycerin, menthol, polyethylene glycol, propylene glycol, purified water, sodium benzoate, sodium citrate, sodium gluconate, sucralose, triacetin, xanthan gum

🎯 Purpose 4 words ▾

Purposes Cough suppressant Expectorant

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 70677-1184-01 · Strategic 70677-1186-01 · Strategic →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.